Access to Medicines

All patients in the EU have a right to access high-quality, patient-centred care in a timely manner. However, there are concerns in Europe and globally that the cost of some new medicines is undermining health systems’ capacity to provide sustainable and equitable access for all.


EPF Publishes Position Paper on ‘The Value and Pricing of Innovative Medicines’ (01/07/2020)